top of page

Pfizer announces results from studies of tofacitinib in ulcerative colitis

Pfizer has announced detailed results from the first two pivotal Phase III studies from the OCTAVE programme.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page